#Seoul #PCR Testing #Seegene #GMCS

Seegene's Call for Comprehensive Syndromic PCR Testing

Seegene Inc., a noted global leader in molecular diagnostics, has recently launched an ambitious initiative known as the Global Million Clinical Study (GMCS). This large-scale project is designed to provide clinical evidence that supports a transition away from traditional virus-specific testing towards a more comprehensive syndromic PCR testing approach. This shift aims to ensure both viral and pneumonia-associated bacterial pathogens are detected simultaneously, thereby improving diagnostic accuracy and patient outcomes.

The Imperative for Change

During their recent analysis of approximately 260,000 pediatric respiratory PCR test results from children between the ages of 0 to 5 years, Seegene uncovered alarming insights regarding the co-occurrence of viral and bacterial pathogens. The results from this study found that conventional infection testing might miss critical co-detections:

• - In tests positive for viruses, 78% also carried pneumonia-causing bacterial pathogens.
• - Conversely, bacterial tests missed viral co-detections in 88% of positive cases.

This data accentuates the critical nature of understanding the complexity behind pediatric respiratory infections, where multiple pathogens often coexist. Relying solely on virus-centered or bacteria-centered tests may paint an incomplete picture, potentially leading to inappropriate clinical decisions.

The High Stakes of Pediatric Respiratory Infections

Pediatric respiratory infections are particularly concerning due to their potential progression to more dangerous conditions like pneumonia and sepsis. This reality underscores the necessity for comprehensive pathogen detection early in patient evaluation processes. The study indicates that when using broad-spectrum testing, a remarkable 96% positivity rate was observed, with 82% of positive cases involving at least two pathogens.